Literature DB >> 18420997

Cholesterol absorption from the intestine is a major determinant of reverse cholesterol transport from peripheral tissue macrophages.

Ephraim Sehayek1, Stanley L Hazen.   

Abstract

OBJECTIVE: We examined the effect of ezetimibe, a cholesterol absorption (CA) inhibitor, and genetic determinants of CA on reverse cholesterol transport (RCT) from subcutaneously injected macrophages using a new dual isotope label technique. METHODS AND
RESULTS: Treatment of C57BL/6J mice with ezetimibe decreased dietary CA by 86% and increased RCT from peripheral tissue macrophages (PTM) by 6-fold (P<0.0001). Moreover, congenic 14DKK mice with a modest 41% decrease in dietary CA displayed a 67% increase in RCT from PTM (P<0.007).
CONCLUSIONS: These findings indicate that pharmacological and genetic modifiers of cholesterol absorption are major determinants of reverse cholesterol transport from peripheral tissue macrophages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18420997      PMCID: PMC2606043          DOI: 10.1161/ATVBAHA.108.165803

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  7 in total

1.  Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice.

Authors:  H R Davis; D S Compton; L Hoos; G Tetzloff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

2.  Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

Authors:  H Buchwald; R L Varco; J P Matts; J M Long; L L Fitch; G S Campbell; M B Pearce; A E Yellin; W A Edmiston; R D Smink
Journal:  N Engl J Med       Date:  1990-10-04       Impact factor: 91.245

3.  A complex plasma plant sterol locus on mouse chromosome 14 has at least two genes regulating intestinal sterol absorption.

Authors:  Ephraim Sehayek; Yee Yan Fung; Hannah J Yu; Jan Lembcke; Uta Ceglarek; Daniel Teupser; Joachim Thiery; Dieter Lutjohann; Klaus von Bergmann; Jan L Breslow
Journal:  J Lipid Res       Date:  2006-07-13       Impact factor: 5.922

4.  Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption.

Authors:  E Sehayek; J G Ono; S Shefer; L B Nguyen; N Wang; A K Batta; G Salen; J D Smith; A R Tall; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

5.  Loci on chromosomes 14 and 2, distinct from ABCG5/ABCG8, regulate plasma plant sterol levels in a C57BL/6J x CASA/Rk intercross.

Authors:  Ephraim Sehayek; Elizabeth M Duncan; Dieter Lutjohann; Klaus Von Bergmann; Jennie G Ono; Ashok K Batta; Gerald Salen; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-22       Impact factor: 11.205

6.  The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

Authors: 
Journal:  JAMA       Date:  1984-01-20       Impact factor: 56.272

7.  Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo.

Authors:  YuZhen Zhang; Ilaria Zanotti; Muredach P Reilly; Jane M Glick; George H Rothblat; Daniel J Rader
Journal:  Circulation       Date:  2003-08-04       Impact factor: 29.690

  7 in total
  26 in total

Review 1.  Therapies targeting exogenous cholesterol uptake: new insights and controversies.

Authors:  Michael H Davidson
Journal:  Curr Atheroscler Rep       Date:  2011-02       Impact factor: 5.113

Review 2.  A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion.

Authors:  Ryan E Temel; J Mark Brown
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

3.  Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model.

Authors:  François Briand; Morgan Tréguier; Agnès André; Didier Grillot; Marc Issandou; Khadija Ouguerram; Thierry Sulpice
Journal:  J Lipid Res       Date:  2009-10-27       Impact factor: 5.922

Review 4.  Experimental models for the investigation of high-density lipoprotein-mediated cholesterol efflux.

Authors:  Carlos G Santos-Gallego; Chiara Giannarelli; Juan José Badimón
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

5.  Lactobacillus acidophilus ATCC 4356 prevents atherosclerosis via inhibition of intestinal cholesterol absorption in apolipoprotein E-knockout mice.

Authors:  Ying Huang; Jinfeng Wang; Guihua Quan; Xiaojun Wang; Longfei Yang; Lili Zhong
Journal:  Appl Environ Microbiol       Date:  2014-09-26       Impact factor: 4.792

Review 6.  High-density lipoprotein heterogeneity and function in reverse cholesterol transport.

Authors:  George H Rothblat; Michael C Phillips
Journal:  Curr Opin Lipidol       Date:  2010-06       Impact factor: 4.776

Review 7.  Intestinal nuclear receptors in HDL cholesterol metabolism.

Authors:  Chiara Degirolamo; Carlo Sabbà; Antonio Moschetta
Journal:  J Lipid Res       Date:  2014-07-28       Impact factor: 5.922

8.  Ezetimibe Increases Endogenous Cholesterol Excretion in Humans.

Authors:  Xiaobo Lin; Susan B Racette; Lina Ma; Michael Wallendorf; Richard E Ostlund
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-09       Impact factor: 8.311

9.  Fatty acid- and cholesterol transporter protein expression along the human intestinal tract.

Authors:  Christiaan J Masson; Jogchum Plat; Ronald P Mensink; Andrzej Namiot; Wojciech Kisielewski; Zbigniew Namiot; Joachim Füllekrug; Robert Ehehalt; Jan F C Glatz; Maurice M A L Pelsers
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

10.  Ezetimibe inhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in mice.

Authors:  Ping Xie; Lin Jia; Yinyan Ma; Juanjuan Ou; Hongming Miao; Nanping Wang; Feng Guo; Amirfarbod Yazdanyar; Xian-Cheng Jiang; Liqing Yu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-07       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.